DR. BRUCE CHRISTOPHER INMAN, M.D.

AVON, IN

Research Active
Surgery NPI registered 21+ years 31 publications 1999 – 2026 NPI: 1699779579
SARS-CoV-2COVID-19PregnancyQuality of LifeCattleDisease-Free SurvivalNeoplasm InvasivenessProstatectomyProstate-Specific AntigenKidney NeoplasmsUrinary Bladder NeoplasmsCattle DiseasesFoot DiseasesHoof and ClawInsemination, Artificial

Practice Location

8244 E US HIGHWAY 36
AVON, IN 46123-9688

Phone: (317) 272-8272

What does BRUCE INMAN research?

Dr. Inman studies several areas within medicine, notably focusing on tuberculosis and bladder cancer. He has developed innovative diagnostic techniques such as FreezeTB, which is designed to quickly identify drug-resistant tuberculosis in patients in Alaska, where cases are prevalent. His research also delves into the effectiveness of urine tests for bladder cancer recurrence and explores various treatment strategies, ranging from focal therapy to hyperthermic treatments for bladder cancer, addressing patient care from early detection to advanced treatment options. In addition, his studies encompass critical care training for healthcare professionals, targeting life-saving procedures like ECMO for patients with severe respiratory problems.

Key findings

  • FreezeTB identified drug resistance mutations in 96% of tuberculosis cases compared to established methods, highlighting its diagnostic effectiveness.
  • In a study of 250 patients with paucibacillary tuberculosis, 24.7% had detectable tuberculosis DNA in stool, improving treatment accuracy.
  • The Bladder EpiCheck test accurately identified 67% of bladder cancer recurrences in a study involving 674 patients, potentially reducing unnecessary invasive procedures.
  • After two years, patients treated with focal therapy for localized prostate cancer showed a cancer recurrence rate of 58-92%, with over 95% free from needing protective pads.
  • Using heated mitomycin C for bladder cancer showed similar recurrence-free rates to standard treatments, indicating no added benefit from the heat technique.

Frequently asked questions

Does Dr. Inman study tuberculosis?
Yes, Dr. Inman focuses on tuberculosis, specifically developing new diagnostic methods for drug-resistant cases.
What treatments has Dr. Inman researched for bladder cancer?
He has researched several treatments for bladder cancer, including focal therapy and hyperthermic treatments, and evaluates the efficacy of urine tests for detecting recurrences.
Is Dr. Inman's research relevant to prostate cancer patients?
Absolutely, his work on focal therapy offers insights and alternative treatment options for patients diagnosed with localized prostate cancer.
Can Dr. Inman's work help patients with low bacterial loads of tuberculosis?
Yes, his research on stool-based testing addresses this issue, improving diagnosis for patients with low bacterial levels.
What is ECMO, and why is it important in Dr. Inman's research?
ECMO stands for Extracorporeal Membrane Oxygenation, a life-support technology that Dr. Inman studied to enhance critical care training for healthcare teams managing serious heart and lung conditions.

Publications in plain English

Application of FreezeTB, a targeted nanopore sequencing assay, for identification of drug resistance and lineages among pulmonary tuberculosis cases in Alaska.

2026

Microbiology spectrum

Inman B, Butler J, George-Nichol S, Kovalenko G, Savidge T +8 more

Plain English
This study focused on developing FreezeTB, a new testing method to identify drug-resistant tuberculosis (TB) in Alaska, where the disease is especially common. The researchers found that FreezeTB accurately detected drug resistance mutations in 96% of the cases when compared to a more established method, while also confirming the genetic lineage of the bacteria in all samples. This is important because it offers a quick, low-cost solution for diagnosing TB and its resistance to treatment, potentially saving lives in high-incidence areas. Who this helps: This benefits patients, healthcare providers, and public health officials working to combat tuberculosis.

PubMed

The use of focal therapy for the treatment of prostate cancer in Canada Where are we, how did we get here, and where are we going?

2025

Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Kumar R, Ghai S, Finelli A, Klotz L, Kinnaird A +8 more

Plain English
This review examines focal therapy as a treatment for localized prostate cancer in Canada, looking at how it's approved, its safety and effectiveness, and ongoing clinical trials. The findings show that after 48 months, 58-92% of patients had no cancer recurrence, over 95% were free from the need for protective pads, and some reported new erectile dysfunction rates between 0-50%. These results indicate that while focal therapy could be effective and have fewer side effects, more in-depth studies are needed to fully understand its benefits compared to standard treatments. Who this helps: This helps patients diagnosed with localized prostate cancer looking for alternative treatment options.

PubMed

Dermal glucocorticoids are uncoupled from stress physiology and infection.

2025

Conservation physiology

Quadros V, Inman B, McDonnell N, Williams K, Romero LM +1 more

Plain English
This study looked at how stress hormones in the skin of amphibians, particularly Eastern red-spotted newts and Northern leopard frogs, relate to their health and survival. The researchers found that these skin hormones did not accurately predict stress or infection levels, but they did indicate how likely the amphibians were to survive in captivity. This matters because it provides insights into how to manage and protect amphibian populations facing decline from various threats. Who this helps: This helps wildlife managers and conservationists working to protect amphibian species.

PubMed

Artificial intelligence may enhance the role of magnetic resonance imaging in prostate cancer focal therapy.

2025

Prostate cancer and prostatic diseases

Au RC, Jenjitranant P, Cool DW, Izawa J, Inman B +2 more

PubMed

Ablative Yttrium-90 Radioembolization Therapy for Nonmetastatic Renal Cell Carcinoma (ARRCC) Phase II Trial.

2025

Journal of vascular and interventional radiology : JVIR

Cool DW, Cardarelli Leite L, Laidley D, Romsa J, Mujoomdar A +4 more

PubMed

Screening and targeted sequencing of stool for microbiologic confirmation and drug resistance determination in paucibacillary tuberculosis.

2025

PLOS global public health

Ness TE, Ziyane M, Maphalala N, Seeger A, Vasiliu A +15 more

Plain English
This study looked at how well stool samples can be used to confirm tuberculosis and check for drug resistance in patients who have a low number of bacteria in their sputum (the substance produced in a cough). In Eswatini, 34% of participants had smear-negative tuberculosis, but among those, 24.7% had enough Mycobacterium tuberculosis DNA in their stool for testing. The stool testing successfully detected the bacteria in 14-19% of cases and identified drug resistance mutations in 12-14% of patients, offering a new way to diagnose and understand treatment options for this hard-to-detect type of tuberculosis. Who this helps: This helps patients with low-bacterial-load tuberculosis and their doctors by providing more reliable diagnostic options.

PubMed

A multidisciplinary discussion of BladderPath.

2024

Canadian Urological Association journal = Journal de l'Association des urologues du Canada

St-Laurent MP, Sfakianos JP, Rose TL, Chung P, Kassouf W +3 more

PubMed

Efficacy of a Single Day Extracorporeal Membrane Oxygenation Training Course for Critical Care Air Transport Team Eligible Personnel.

2024

Military medicine

Paredes RM, Inman B, Davis WT, Castaneda M, Mireles AA +5 more

Plain English
The study examined a one-day training course on Extracorporeal Membrane Oxygenation (ECMO), which is a life-support technology for patients with severe heart and lung issues. Seventeen teams of military doctors and nurses completed the training, and all of them (100%) successfully placed a simulated patient on the ECMO system, with 15 teams moving on to a more complex setup. After the course, participants' knowledge improved by over 12% and their confidence increased by 41%. Who this helps: This helps military medical personnel and ultimately the patients they care for in critical situations.

PubMed

North American study and meta-analysis evaluating performance of Bladder EpiCheck, a FDA cleared test, in non-muscle invasive bladder cancer recurrence.

2024

Bladder cancer (Amsterdam, Netherlands)

Fleshner N, Grossman HB, Berglund R, Hafron J, Inman B +7 more

Plain English
This study focused on a urine test called Bladder EpiCheck (BE) designed to detect recurrences of bladder cancer that hasn't invaded the muscle. Researchers assessed 674 bladder cancer patients, finding that the test accurately identified 67% of recurrences while correctly indicating non-recurrence 84% of the time. This matters because it can help doctors detect bladder cancer earlier and reduce unnecessary procedures, minimizing stress for patients. Who this helps: Patients at risk for non-muscle invasive bladder cancer recurrence.

PubMed

Thoracic Spinal Nerve Neuromodulation Therapy for Diabetic Gastroparesis: A Proof-of-Concept Study.

2023

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Karunaratne T, Yan Y, Eubanks A, Inman B, Rao S +1 more

PubMed

Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial.

2023

European urology oncology

Angulo JC, Álvarez-Ossorio JL, Domínguez-Escrig JL, Moyano JL, Sousa A +10 more

Plain English
This study looked at a treatment for intermediate-risk non-muscle-invasive bladder cancer by comparing the effects of administering mitomycin C at normal temperature versus at a higher temperature (43°C) for 30 and 60 minutes. After two years, the recurrence-free survival rates were similar: 77% for the regular treatment, 82% for the 30-minute heated treatment, and 80% for the 60-minute heated treatment, indicating no significant advantage to the heated treatment. This research is important because it helps clarify that using heat to administer this medication does not provide additional benefits, which can help guide treatment options for patients with this type of cancer. Who this helps: This helps patients with intermediate-risk non-muscle-invasive bladder cancer.

PubMed

High risk and low prevalence diseases: Toxic alcohol ingestion.

2023

The American journal of emergency medicine

Inman B, Maddry JK, Ng PC, Koyfman A, Long B

Plain English
This study focuses on the dangers of ingesting toxic alcohols, which are rare but can seriously harm health or even be fatal. It emphasizes the importance of quickly recognizing the symptoms, as timely diagnosis and treatment can prevent severe damage to organs. For instance, when diagnosed properly, doctors can use treatments like fomepizole or ethanol to counteract the effects of these toxic substances. Who this helps: Patients who accidentally or intentionally ingest toxic alcohols and the doctors treating them.

PubMed

Sigmoid volvulus after trauma, an uncommon twist.

2022

The American journal of emergency medicine

Mongold S, Inman B, Long B, Cibrario A, Bridwell RE

Plain English
This study looked at a rare case of sigmoid volvulus, which is when a part of the colon twists and cuts off its blood supply, following an injury from a car accident. The patient didn't have any prior bowel issues, but quick action by emergency doctors led to successful surgery, preventing serious complications. This finding is important because it highlights the need for emergency teams to recognize and treat this condition quickly, even in patients without a typical history of it. Who this helps: This helps emergency doctors and trauma patients.

PubMed

STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine.

2021

The Journal of emergency medicine

Azir M, Inman B, Webb J, Tannenbaum L

Plain English
Researchers studied a 17-year-old boy who developed a heart condition called myocarditis, which can mimic a serious heart attack, just three days after getting the mRNA COVID-19 vaccine. While this type of heart inflammation is very rare, it can show signs similar to a heart attack on an EKG. Understanding this helps doctors recognize and differentiate between symptoms linked to the vaccine and more serious heart issues. Who this helps: This information benefits doctors and healthcare providers treating young patients after vaccination.

PubMed

Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review.

2018

European urology

Fonteyne V, Ost P, Bellmunt J, Droz JP, Mongiat-Artus P +4 more

Plain English
The study looked at how well older patients (over 70 years old) with muscle invasive bladder cancer (MIBC) do after receiving curative treatments, compared to younger patients. It found that older patients have a significantly lower overall survival rate (OS) and cancer-specific survival rate (CSS), and face higher risks of complications (POM) after surgery or radiation, although the overall complication rate was similar for both age groups. This matters because it highlights the need for careful evaluation of treatment plans for elderly patients to ensure they truly benefit from aggressive treatments without compromising their quality of life. Who this helps: This helps doctors and healthcare providers make better treatment decisions for older patients with bladder cancer.

PubMed

Need for Evidence and Consensus on Laser Treatment for Management of Select Primary Penile Tumors.

2017

European urology

Leone A, Inman B, Spiess PE

Plain English
This study looked at using laser treatment for low-risk penile tumors and found it to be effective, providing good cancer control and preserving functionality for patients. However, patients need to be closely monitored over time because there is a significant chance that the tumors could come back. This research is important because it highlights the need for clear guidelines and ongoing care for those undergoing this treatment. Who this helps: Patients with low-risk primary penile tumors.

PubMed

Betrixaban, sofosbuvir/velpatasvir/voxilaprevir, and glecaprevir/pibrentasvir.

2017

Journal of the American Pharmacists Association : JAPhA

Hussar DA, Inman B

PubMed

Inflammation: A Significant Contributor to Upper-tract Urothelial Carcinoma Prognosis?

2015

European urology focus

Inman B, Tay KJ

PubMed

Risk for transmission of Naegleria fowleri from solid organ transplantation.

2014

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Roy SL, Metzger R, Chen JG, Laham FR, Martin M +21 more

Plain English
This study looked at the risk of transmitting a dangerous amoeba called Naegleria fowleri through solid organ transplants. Between 1995 and 2012, 21 patients received organs from donors who had died from this amoeba, but none of them got sick, and some tested negative for the amoeba. However, there are concerns that the amoeba could still be present in organs and might pose a risk, so doctors need to carefully consider this when deciding on organ transplants. Who this helps: This information helps doctors and patients making decisions about organ transplants.

PubMed

Bone density changes in bovine toe necrosis.

2013

The Veterinary record

Blowey R, Burgess J, Inman B, Evans N

PubMed

Preclinical Dosimetry of Magnetic Fluid Hyperthermia for Bladder Cancer.

2013

Proceedings of SPIE--the International Society for Optical Engineering

Oliveira TR, Stauffer PR, Lee CT, Landon C, Etienne W +3 more

Plain English
This study explored the use of magnetic fluid hyperthermia (MFH) to treat bladder cancer in rats. Researchers injected nanoparticles into the rats' bladders and successfully raised the bladder temperature to 42°C within 10 minutes while keeping it stable for 60 minutes. They found that the heat was well-targeted to the bladder with minimal impact on surrounding tissues, making this method a promising option for future bladder cancer treatments. Who this helps: This helps patients with bladder cancer by providing a potential new treatment option.

PubMed

Magnetic fluid hyperthermia for bladder cancer: a preclinical dosimetry study.

2013

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Oliveira TR, Stauffer PR, Lee CT, Landon CD, Etienne W +8 more

Plain English
This study looked at a new way to treat bladder cancer using a technique called magnetic fluid hyperthermia, which heats cancerous cells using special nanoparticles. In tests with 25 rats, researchers successfully raised the temperature in the bladder to 42°C within 10 minutes and kept it steady for one hour, without harming nearby tissues. This is important because it shows a potential method for effectively targeting and killing cancer cells in the bladder while protecting healthy tissue. Who this helps: This helps patients with bladder cancer.

PubMed

Bilateral renal cell carcinoma in a child.

2012

Urology

Cloutier J, Aziz A, Inman B, Bolduc S

Plain English
This study focuses on a rare case of bilateral renal cell carcinoma, a type of kidney cancer, in a child, which is only seen in 0.1-0.3% of cases. The child underwent surgeries to remove part of both kidneys and, after 80 months of follow-up, showed no signs of cancer returning and had normal kidney function. This is significant because it highlights the potential for successful treatment and good outcomes in children with this unusual condition. Who this helps: This helps pediatric patients diagnosed with kidney cancer and their doctors.

PubMed

Measles, rubella, and varicella among the crew of a cruise ship sailing from Florida, United States, 2006.

2012

Journal of travel medicine

Mitruka K, Felsen CB, Tomianovic D, Inman B, Street K +2 more

Plain English
A study investigated an outbreak of measles, rubella, and chickenpox (varicella) among the crew of a cruise ship traveling from Florida to the Caribbean between February and April 2006. Researchers found 16 cases of these diseases among crew members, including 3 cases of measles and 11 cases of chickenpox, and only 4 crew members had proof of immunity to measles and rubella. This situation highlights the importance of ensuring that cruise ship crews are vaccinated against these diseases to prevent their spread, which also protects passengers and the wider community. Who this helps: This helps cruise ship passengers and crew members.

PubMed

Is there a case for reassessing hoof-trimming protocols?

2012

The Veterinary record

Blowey R, Inman B

PubMed

Pregnancy rates in angus cross beef cows bred at observed oestrus with or without second GnRH administration in fixed-time progesterone-supplemented Ovsynch and CO-Synch protocols.

2010

Reproduction in domestic animals = Zuchthygiene

Kasimanickam R, Hall JB, Currin JF, Inman B, Rudolph JS +1 more

Plain English
This study looked at how pregnancy rates in beef cows are affected by hormone treatments and whether a second hormone dose improves results. Researchers synchronized the oestrous cycles of over 1,000 cows and found that pregnancy rates were similar whether cows received a second dose of a hormone called GnRH or not, maintaining rates around 80% for both methods. This is important because it shows that farmers can achieve good pregnancy rates in their cattle without needing to monitor heat cycles closely, simplifying the breeding process. Who this helps: This helps farmers and veterinarians working with beef cattle.

PubMed

After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.

2008

BJU international

Sengupta S, Blute ML, Bagniewski SM, Inman B, Leibovich BC +3 more

Plain English
This study examined the progression and survival rates of men with what is considered "insignificant" prostate cancer after surgery, comparing it to those with low-risk but "significant" prostate cancer. Out of nearly 6,500 men, 354 had "insignificant" cancer and showed similar long-term outcomes; both groups had around 87% of patients free from disease progression after ten years. This matters because it challenges the notion that "insignificant" prostate cancer does not require close monitoring, suggesting that its outcomes can be similar to more serious forms of cancer. Who this helps: This helps patients diagnosed with early-stage prostate cancer and their doctors in making informed treatment decisions.

PubMed

Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study.

2008

The Journal of urology

Siddiqui SA, Boorjian SA, Inman B, Bagniewski S, Bergstralh EJ +1 more

Plain English
This study investigated how the timing of hormone therapy, known as androgen deprivation therapy, affects survival in men with localized prostate cancer who had their prostate removed. Researchers found that men who started hormone therapy right after surgery (adjuvant therapy) had a 95% chance of avoiding disease progression after 10 years, compared to 90% for those who did not receive this therapy. However, starting hormone therapy later did not improve survival outcomes, suggesting that immediate treatment after surgery is more beneficial. Who this helps: This helps patients with localized prostate cancer and their doctors make informed decisions about post-surgery treatment options.

PubMed

A field study of the effects of a monovalent Leptospira borgpetersenii serovar Hardjo strain hardjobovis vaccine administered with oxytetracycline on reproductive performance in beef cattle.

2007

Journal of the American Veterinary Medical Association

Kasimanickam R, Whittier WD, Collins JC, Currin JF, Inman B +2 more

Plain English
This study looked at whether a specific vaccine for leptospirosis, along with a medication called oxytetracycline, could improve the reproductive success of beef cattle. Researchers tested 1,446 Angus-cross cows and found no significant difference in pregnancy rates between those who received the vaccine and those who did not. This matters because it suggests that using this vaccine and medication combination doesn't enhance reproductive outcomes in beef cattle, even in areas where leptospirosis is present. Who this helps: This helps farmers and ranchers by providing clarity on vaccination strategies for improving cattle reproduction.

PubMed

The role of partial nephrectomy for the management of sporadic renal angiomyolipoma.

2007

Urology

Boorjian SA, Frank I, Inman B, Lohse CM, Cheville JC +2 more

Plain English
This study looked at how well a type of kidney surgery called nephron-sparing surgery works for patients with a non-cancerous kidney tumor known as renal angiomyolipoma. Researchers examined 58 patients who underwent this surgery and found that only 12% experienced early complications, with 3 individuals having a urine leak. After an average follow-up of 8 years, only 3.4% had signs of the tumor returning, and importantly, there were no new cases of chronic kidney problems after the surgery. Who this helps: This benefits patients with renal angiomyolipoma, especially those who want to preserve their kidney function.

PubMed

Microchimerism in sensitized renal patients.

1999

Transplantation

Inman B, Halloran B, Melk A, Ramassar V, Halloran PF

Plain English
This study looked at women waiting for kidney transplants who had developed antibodies against human tissue, even without recent exposure to it. Researchers found that 3 out of 10 patients had traces of foreign DNA from male cells in their blood, which could explain why their immune systems were still reacting. This is important because it suggests that these lingering cells might play a role in maintaining the immune response, impacting how doctors treat sensitized patients. Who this helps: This helps patients waiting for kidney transplants and their doctors.

PubMed

Frequent Co-Authors

Michael L Blute Alexander Kay Anna Mandalakas Tara E Ness Derek W Cool Patrick C Ng Joseph K Maddry Brit Long Tiago R Oliveira Paul R Stauffer

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.